Artesunate/Pyronaridine Phosphate
- Generic Name
- Artesunate/Pyronaridine Phosphate
Pilot Clinical Trial to Explore Efficacy and Safety of Pyramax in Mild to Moderate COVID-19 Patients
- First Posted Date
- 2022-12-01
- Last Posted Date
- 2022-12-02
- Lead Sponsor
- Shin Poong Pharmaceutical Co. Ltd.
- Target Recruit Count
- 20
- Registration Number
- NCT05633420
- Locations
- 🇰🇷
Inje University Ilsan Paik Hospital, Goyang-si, Gyeonggi-do, Korea, Republic of
🇰🇷Inha University Hospital, Incheon, Korea, Republic of
The Efficacy and Safety of Pyramax in Mild to Moderate COVID-19 Patients (Phase3)
- First Posted Date
- 2021-10-20
- Last Posted Date
- 2023-06-18
- Lead Sponsor
- Shin Poong Pharmaceutical Co. Ltd.
- Target Recruit Count
- 1807
- Registration Number
- NCT05084911
- Locations
- 🇦🇷
Instituto Medico Platense, Buenos Aires, Argentina
🇰🇷Seoul Red Cross Hospital, Seoul, Korea, Republic of
🇨🇴IPS Centro Cientifico Asisitencial S.A.S, Barranquilla, Colombia
Comparison of ISTp- PYRAMAX-US-RDT to IPTp-SP to Prevent Malaria in Pregnant Women in DRC (ULTRAPYRAPREG)
Phase 3
Completed
- Conditions
- Malaria in Pregnancy
- Interventions
- First Posted Date
- 2021-03-04
- Last Posted Date
- 2022-11-04
- Lead Sponsor
- University of Kinshasa
- Target Recruit Count
- 250
- Registration Number
- NCT04783051
- Locations
- 🇨🇩
Maternité Esengo, Kinshasa, Congo, The Democratic Republic of the
Pyronaridine Artesunate-Ritonavir Drug-drug Interaction Study
- First Posted Date
- 2010-07-02
- Last Posted Date
- 2023-02-03
- Lead Sponsor
- Medicines for Malaria Venture
- Target Recruit Count
- 34
- Registration Number
- NCT01156389
- Locations
- 🇨ðŸ‡
Covance Clinical Research Unit AG, Allschwil, Basel, Switzerland
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath